Title : Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301.

Pub. Date : 2004 Feb

PMID : 15005346






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase III study of ranimustine, cyclophosphamide, vincristine, melphalan, and prednisolone (MCNU-COP/MP) versus modified COP/MP in multiple myeloma: a Japan clinical oncology group study, JCOG 9301. Prednisolone caspase recruitment domain family member 16 Homo sapiens